ABSTRACT Introduction Coronavirus disease 2019 (COVID-19) has the characteristics of
high transmission, diverse clinical manifestations, and a long incubation period. In addition …

Despite intense research there is currently no effective vaccine available against the new
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in the later 2019 …

Electronic health records (EHR) contain large volumes of unstructured text, requiring the
application of information extraction (IE) technologies to enable clinical analysis. We present …

Abstract Background The National Early Warning Score (NEWS2) is currently recommended
in the UK for the risk stratification of COVID-19 patients, but little is known about its ability to …

Introduction The cytokine release syndrome (CRS) of COVID-19 is associated with the
development of critical illness requiring multi-organ support. Further research is required to …

Background and objectives With the increase in the number of COVID-19 infections, the
global health apparatus is facing insufficient resources. The main objective of the current …

Background and rationale Some studies of hospitalized patients suggested that the risk of
death and/or severe illness due to COVID-19 is not associated with the use of angiotensin …

Obesity and diabetes are established comorbidities for COVID-19. Adipose tissue
demonstrates high expression of ACE2 which SARS-CoV-2 exploits to enter host cells. This …

Background Despite its clinical significance, the risk of severe infection requiring
hospitalization among outpatients with severe acute respiratory syndrome coronavirus 2 …

Discovery of ACE2 (angiotensin-converting enzyme 2) revealed that the renin-angiotensin
system has 2 counterbalancing arms. ACE2 is a major player in the protective arm, highly …